1 Million AstraZeneca Doses Coming, But No More Opt-In!

Spread the love

More than 1 million more doses of the AstraZeneca vaccine are coming in, but they will no longer be available through the opt-in programme!


1 Million AstraZeneca Doses Coming, But No More Opt-In!

Malaysians are extremely worried, with over 7,000 new cases per day. That’s why the recent AstraZeneca 2.0 vaccine programme ran out in just over an hour!

But not to worry – a million more AstraZeneca vaccine doses are arriving in the next two months610,000 doses in June, and 410,000 doses in July!

These vaccine doses are manufactured by the AstraZeneca in Thailand, and therefore, is still subject to NPRA’s approval.

However, the government has decided to stop offering any AstraZeneca opt-in programmes in the future. There will be no longer be an AstraZeneca 3.0 programme, I’m afraid!

Once NPRA approves these Thai-manufactured AstraZeneca vaccine doses, they will be used together with the Pfizer and Sinovac vaccines in the main COVID-19 vaccination programme.

1 Million AstraZeneca Doses Coming, But No More Opt-In!


AstraZeneca Vaccine : Is It Safe To Get?

Many people are worried about the risk of getting blood clots from the AstraZeneca vaccine.

The fact is – the risk is incredibly small – certainly much, MUCH smaller than the risk of developing blood clots with COVID-19, which can be as high as 41% in positive patients, and up to 95% in severe COVID-19 cases.

Blood clots can also develop (through different mechanisms) with smoking and the use of oral contraceptive pills (OCP).

We created this table to better demonstrate the risk to you.

Risk Difference
Thrombocytopenia in
severe COVID-19 cases
Up to 95% 45,238X
in COVID-19 cases
Up to 41% 19,524X
Dying from COVID-19 Infection 0.25% to
119X to 4762X
Thrombosis from OCP
Up to 0.46% 219X
Thrombosis from Smoking 0.18% 85.7X
Thrombosis from OCP
Up to 0.01% 4.8X
Thrombotic Thrombocytopenia
(AstraZeneca Vaccine)
0.0021% Baseline

So, is it safe to get the AstraZeneca vaccine that’s being offered to people age 18 years and above in Malaysia?

We can only tell you that the risk is exceedingly low. At most, 21 out of 1 million people who receive this vaccine will potentially develop this condition.

Based on the risk-benefit analysis performed by the EMA Committee for Medicinal Products for Human Use (CHMP), it is obvious that for a high-incidence country like Malaysia, the benefits far outweigh the risks.

More importantly, that we are aware of this particular side effect, both doctors and vaccine recipients can look out for the symptoms and quickly seek treatment.

Recommended : AstraZeneca Vaccine In Malaysia : Is It Safe To Get?
Recommended : AstraZeneca Vaccine Blood Clot Risk : How Dangerous Is It?


Recommended Reading

Go Back To > Health | Tech ARP


Support Tech ARP!

If you like our work, you can help support us by visiting our sponsors, participating in the Tech ARP Forums, or even donating to our fund. Any help you can render is greatly appreciated!

About The Author

Leave a Reply